E Fund Hang Seng SCHK Innovative Drug ETF
1593161.1040.18% ( -0.002 )
E Fund Hang Seng SCHK Innovative Drug ETF (159316)
- Open
- 1.100
- High
- 1.116
- Low
- 1.097
- Prev. Close
- 1.106
- Volume
- 6.33M
- Turnover
- 701.09M
- Avg Price
- 1.107
- Bid/Ask Ratio
- -6.32%
- Amplitude
- 1.72%
- 52wk High
- 1.715
- Volume Ratio
- 0.46
- Turnover Ratio
- 0.00%
News
- PUBT · 2 hours ago
CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057
- PUBT · 1 day ago, 07:34 AM
CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancer
- AASTOCKS News · Jul 27 at 09:07 PM
CSPC PHARMA Marketing Application for Sirolimus for Injection Accepted
- AASTOCKS News · Jul 27 at 09:07 PM
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical Trial
- Tip Ranks · 2 days ago, 07:36 PM
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
- PUBT · Jul 27 at 07:58 AM
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority review
